Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-02-24 @ 9:00 AM
Study NCT ID:
NCT02538120
Status:
COMPLETED
Last Update Posted:
2016-02-12
First Post:
2015-08-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 Patients
Sponsor:
University Hospital, Angers
Organization:
Study Overview
Official Title:
Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NEURODIAB1
Brief Summary:
This study aims to see whether or not the diabetes 1 patients have a neurovascular microcirculatory dysfunction using various microvascular tests which have been previously validated.
Microvascular responses will be assessed by Laser Speckle Contrast Imaging and expressed in Laser Speckle Perfusion Units (LSPU).
Microvascular responses will be assessed by Laser Speckle Contrast Imaging and expressed in Laser Speckle Perfusion Units (LSPU).
Detailed Description:
The investigators will compare microvascular responses between diabetes type 1 patients with matched control-subjects.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: